This website can be best viewed in Microsoft Internet Explorer 9.0+, Chrome, Firefox

For Appointments / OPD

Hospital No.  :23667900 (Mon/Tue/Thu/Fri 5-8 PM)
Clinic No.      :22046210 (Mon-Fri 6-8 PM)
Doctor No.    :
Secretary No.:9619846210 Only SMS (Mon-Fri 5-8 PM)
Days Timings
Monday16.00-20.00
Tuesday16.00-20.00
Thursday16.00-20.00
Friday16.00-20.00

Dr. Zarir F. Udwadia (Coordinator)

 

 

MD, DNB, FRCP (London.), and FCCP (USA).

A post-graduate of the Grant Medical College, Bombay, he has spent 5 years training in various centers of excellence in the U.K including the prestigious Brompton Hospital, London.

 

 

Dr Zarir F Udwadia is a consultant chest physician at the Hinduja Hospital, Breach Candy Hospital and Parsee General Hospitals.
3 decades of experience in treating a range of pulmonary and general medical problems.

Tuberculosis and Specifically Drug Resistant TB

Dr Udwadia is actively involved in TB research collaborations with partners from across the globe.

The Economic Times included him in their list of "India's 15 strategists: dreamers who have translated insight into reality” with the citation reading "his contribution to understanding the gravity of the scourge called TB is outstanding."

Interstitial Lung Disease

This is an area of interest and research.He was invited in 2009 to contribute the chapter on ‘ILD: an Indian perspective’ in the prestigious ERS monograph. He was the sole Indian invited by the American Thoracic Society to be a member of the international multidisciplinary consensus panel to develop a consensus classification on ILD.

HIV

He was the first to isolate the HIV 2 virus from the lung of a patient, a finding reported in Thorax.

Sleep Medicine

He has extensive experience in diagnosing and treating patients with sleep disorders.

Tropical Lung Disease
His work on the epidemiology of community acquired pneumonia is one of the only epidemiological studies of Pneumonia from this country

Bronchoscopy

Was trained in a variety of bronchoscopic techniques in the UK and has performed large numbers of bronchoscopies and transbronchial lung biopsies in a wide range of different diseases. He continues to be actively involved with patient care and research at the Hinduja Hospital with areas of ongoing research being tuberculosis, drug-resistant tuberculosis, interstitial lung disease, pneumonia, sleep disorders and sarcoidosis.

 

 

  • Dr Rangarajan Memorial Oration on Drug Resistant TB, 2015.
  • Dr Ellis Oration on India’s MDR-TB crisis, 2001.
  • The Dr. Swamy award for the best Post-Graduate thesis submitted for the M.D. exams.
  • Medicine amongst Post-Graduate registered students in medicine.
  • The Dr. Govind Vishnu Juvekar Prize in IIIrd M.B.B.S.
  • D.R. Bardi Gold Medal and Book Prize in IIIrd M.B.B.S.
  • Lieutenant Colonel Eduljee Maneckji Damla Silver Medal in IInd M.B.B.S
  • Max Lennan Scholarship in IIIrd M.B.B.S.
  • The Mancherji P. Choksey Memorial Gold Medal in IIIrd M.B.B.S.
  • The Dr. A.J. Kohiyar Prize 1984 for standing 1st in the IIIrd M.B.B.S Examinations in
  • The Dr. A.J. Kohiyar Oration delivered on 29th March 1985 under the auspices of “The Research Society” of Grant Medical College at its Annual Conference.
  • The Searle Award for the best original research paper presented at the 43rd Annual Conference of the Cardiology Society of India, November 22, 1991.
  • Dr Kapadia Oration on HIV and the lungs, 2004.
  • On the editiorial board of the International Journal – Thorax.
 

 

Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India. Int J Tuberc Lung Dis. 2016 Dec;20(12):1633-1638

Imatinib-induced pleural effusion: A case report. J Postgrad Med. 2016 Nov 16. doi: 10.4103/0022-3859.194227.

Corrigendum to "Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables" . Int J Mycobacteriol. 2016 Sep;5(3):370-372.

Therapeutic choices in rifampicin-resistant tuberculosis. Lancet Infect Dis.2016 Nov;16(11):1220-1221 https://www.ncbi.nlm.nih.gov/pubmed/27788974

Importance of Therapeutic Drug Monitoring of Rifampicin. J Assoc Physicians India. 2016 Aug;64(8):68-72.